Audio Journal of Cardiovascular Medicine 11.1, January 2005

Reporting from:
American Heart Association Scientific Sessions, New Orleans, November 7-10, 2004

In this edition:

In severe heart failure, Teresa De Marco told delegates at the American Heart Association meeting, vasodilators bring better survival rates as first line therapy than inotropes.

Marc Pfeffer’s results show that adding extra medications such as ACE inhibitors may not improve outcomes - contradicting received wisdom from another recent study.

A synthetic jacket acting like a support stocking can bring benefit to the failing heart, according to Douglas Mann who described his investigation at the New Orleans conference.

Anthony Gerschlick has discovered that in centres where lytic therapy for infarction is the first line of attack, patients needing further rescue should receive angioplasty and not repeat lysis.

David Malenka told the conference how his team found that bypass grafting was better than angioplasty in three-vessel disease.

The idea of getting barbers to screen for blood pressure was raised at the New Orleans conference by Paul Hess following a successful trial conducted by his group.
…

Click here for more.

Audio Journal of Oncology 13.1, January 2005

Reporting from:
- European Society for Medical Oncology Congress, October 29-November 10, 2004, Vienna
- Journal of Clinical Oncology
- New England Journal of Medicine
- Lancet

In this edition:

The ESMO conference in Vienna heard news from Charles Butts that patients with advanced lung cancer have responded to a vaccine.

Diane Harper describes from her article the protection a vaccine has given against human papillomavirus types 16 and 18, raising hopes that widespread prevention of cervical cancer could be undertaken by immunization.

Daniel Haller told delegates at ESMO that his phase III study shows that the IROX combination of irinotecan plus oxaliplatin is superior to irinotecan monotherapy and does not add toxicity.

George Canellos reflects on the immune processes holding follicular lymphoma cells in check as revealed by a New England Journal of Medicine article looking at gene profiles and their prognostic implications for this variable disease.
…

Click here for more.